Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Open-label, Controlled Trial To Assess The Safety And Tolerability Of Lucinactant For Inhalation In Preterm Neonates 26 to 28 Weeks PMA
Conditions
Interventions
Lucinactant for inhalation
nCPAP alone
Locations
20
United States
Loma Linda University Medical Center
Loma Linda, California, United States
Sharp Mary Birch Hospital for Women and Newborns
San Diego, California, United States
Christiana Care Health System
Newark, Delaware, United States
University of Miami
Miami, Florida, United States
University of Louisville
Louisville, Kentucky, United States
University of Nebraska Medical Center
Omaha, Nebraska, United States
Start Date
August 1, 2015
Primary Completion Date
May 31, 2017
Completion Date
August 11, 2017
Last Updated
July 23, 2019
NCT04565665
NCT07504731
NCT07450846
NCT07414056
NCT06701669
NCT07262541
Lead Sponsor
Windtree Therapeutics
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions